Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$1.19 - $1.79 $13,018 - $19,582
10,940 New
10,940 $15,000
Q4 2022

Feb 15, 2023

SELL
$0.46 - $8.9 $102 - $1,984
-223 Reduced 1.52%
14,494 $7,000
Q3 2022

Nov 07, 2022

BUY
$0.08 - $22.6 $1,177 - $332,604
14,717 New
14,717 $12,000
Q1 2022

May 17, 2022

SELL
$2.96 - $8.01 $61,399 - $166,151
-20,743 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$7.21 - $16.42 $149,557 - $340,600
20,743 New
20,743 $163,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0

About Jasper Therapeutics, Inc.


  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $843M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.